• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯耐碳青霉烯类肠杆菌科的分子流行病学和结果。

Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.

机构信息

King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.

Alfaisal University, Riyadh, Saudi Arabia.

出版信息

BMC Infect Dis. 2022 Jun 13;22(1):542. doi: 10.1186/s12879-022-07507-y.

DOI:10.1186/s12879-022-07507-y
PMID:35698046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9190113/
Abstract

BACKGROUND

The burden of carbapenem resistance is not well studied in the Middle East. We aimed to describe the molecular epidemiology and outcome of carbapenem-resistant Enterobacterales (CRE) infections from several Saudi Arabian Centers.

METHODS

This is a multicenter prospective cohort study conducted over a 28-month period. Patients older than 14 years of age with a positive CRE Escherichia coli or Klebsiella pneumoniae culture and a clinically established infection were included in this study. Univariate and multivariable logistic models were constructed to assess the relationship between the outcome of 30-day all-cause mortality and possible continuous and categorical predictor variables.

RESULTS

A total of 189 patients were included. The median patient age was 62.8 years and 54.0% were male. The most common CRE infections were nosocomial pneumonia (23.8%) and complicated urinary tract infection (23.8%) and 77 patients (40.7%) had CRE bacteremia. OXA-48 was the most prevalent gene (69.3%). While 100 patients (52.9%) had a clinical cure, 57 patients (30.2%) had died within 30 days and 23 patients (12.2%) relapsed. Univariate analysis to predict 30-day mortality revealed that the following variables are associated with mortality: older age, high Charlson comorbidity index, increased Pitt bacteremia score, nosocomial pneumonia, CRE bacteremia and diabetes mellitus. In multivariable analysis, CRE bacteremia remained as an independent predictor of 30 day all-cause mortality [AOR and 95% CI = 2.81(1.26-6.24), p = 0.01].

CONCLUSIONS

These data highlight the molecular epidemiology and outcomes of CRE infection in Saudi Arabia and will inform future studies to address preventive and management interventions.

摘要

背景

在中东,碳青霉烯类耐药的负担尚未得到充分研究。我们旨在描述来自沙特阿拉伯几个中心的碳青霉烯类耐药肠杆菌科(CRE)感染的分子流行病学和结果。

方法

这是一项为期 28 个月的多中心前瞻性队列研究。纳入年龄大于 14 岁且具有阳性 CRE 大肠埃希菌或肺炎克雷伯菌培养和临床确诊感染的患者。采用单变量和多变量逻辑模型来评估 30 天全因死亡率的结果与可能的连续和分类预测变量之间的关系。

结果

共纳入 189 例患者。患者的中位年龄为 62.8 岁,54.0%为男性。最常见的 CRE 感染是医院获得性肺炎(23.8%)和复杂性尿路感染(23.8%),77 例(40.7%)患者发生 CRE 菌血症。最常见的基因是 OXA-48(69.3%)。虽然 100 例(52.9%)患者临床治愈,但 57 例(30.2%)在 30 天内死亡,23 例(12.2%)复发。预测 30 天死亡率的单变量分析显示,以下变量与死亡率相关:年龄较大、较高的 Charlson 合并症指数、增加的 Pitt 菌血症评分、医院获得性肺炎、CRE 菌血症和糖尿病。多变量分析显示,CRE 菌血症仍然是 30 天全因死亡率的独立预测因素[优势比和 95%置信区间=2.81(1.26-6.24),p=0.01]。

结论

这些数据突出了沙特阿拉伯 CRE 感染的分子流行病学和结果,并将为未来的研究提供信息,以解决预防和管理干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e62/9190113/8324f20ddac2/12879_2022_7507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e62/9190113/8324f20ddac2/12879_2022_7507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e62/9190113/8324f20ddac2/12879_2022_7507_Fig1_HTML.jpg

相似文献

1
Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.沙特阿拉伯耐碳青霉烯类肠杆菌科的分子流行病学和结果。
BMC Infect Dis. 2022 Jun 13;22(1):542. doi: 10.1186/s12879-022-07507-y.
2
Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.耐碳青霉烯肠杆菌科:来自沙特阿拉伯的更新叙述性综述。
J Infect Public Health. 2019 Jul-Aug;12(4):465-471. doi: 10.1016/j.jiph.2019.03.024. Epub 2019 May 3.
3
Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.与碳青霉烯类耐药肠杆菌科感染的流行和治疗相关的因素:在三家三级保健医院进行的一项为期七年的回顾性研究。
Ann Clin Microbiol Antimicrob. 2018 Mar 23;17(1):13. doi: 10.1186/s12941-018-0267-8.
4
Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.南非三级医院血培养阳性患者中产碳青霉烯类肠杆菌科细菌,2015 年至 2018 年。
Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1287-1294. doi: 10.1007/s10096-020-03845-4. Epub 2020 Mar 2.
5
Risk Factors for Carbapenem-Resistant Clinical Treatment Failure.碳青霉烯类耐药临床治疗失败的危险因素。
Microbiol Spectr. 2023 Feb 14;11(1):e0264722. doi: 10.1128/spectrum.02647-22. Epub 2023 Jan 9.
6
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.比较产碳青霉烯酶与不产碳青霉烯酶的耐碳青霉烯类肠杆菌科细菌血症患者的结局
Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9.
7
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.耐碳青霉烯类肠杆菌科细菌感染的流行病学:来自中国 CRE 网络的报告。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01882-17. Print 2018 Feb.
8
The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study.南非医院碳青霉烯类耐药肠杆菌科血流感染患者中,与其他抗菌药物相比,含黏菌素方案对死亡率的影响:一项横断面研究。
BMC Infect Dis. 2024 Jun 5;24(1):561. doi: 10.1186/s12879-024-09459-x.
9
Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.中国一项多中心研究:碳青霉烯类耐药肠杆菌科引起的复杂性腹腔内感染的危险因素和分子流行病学。
J Infect Dis. 2020 Mar 16;221(Suppl 2):S156-S163. doi: 10.1093/infdis/jiz574.
10
Molecular characterization of carbapenem-resistant in thirteen tertiary care hospitals in Saudi Arabia.沙特阿拉伯 13 家三级护理医院耐碳青霉烯肠杆菌的分子特征。
Ann Saudi Med. 2021 Mar-Apr;41(2):63-70. doi: 10.5144/0256-4947.2021.63. Epub 2021 Apr 1.

引用本文的文献

1
Epidemiology and outcomes of Carbapenem-resistant Enterobacterales infection in high-risk patients in Saudi Arabia.沙特阿拉伯高危患者中耐碳青霉烯类肠杆菌科细菌感染的流行病学及转归
Front Microbiol. 2025 Aug 19;16:1619611. doi: 10.3389/fmicb.2025.1619611. eCollection 2025.
2
Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013-2023.海湾合作委员会地区的菌血症:2013 - 2023年文献综述
Infect Drug Resist. 2025 May 7;18:2329-2355. doi: 10.2147/IDR.S497241. eCollection 2025.
3
Molecular Analysis of Tigecycline Resistance in Carbapenem-Resistant Enterobacterales (CRE) in Mthatha and Surrounding Hospitals.

本文引用的文献

1
Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant .碳青霉烯类耐药菌引起的血流感染的死亡率相关风险因素评估和有效抗菌治疗方案。
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0069821. doi: 10.1128/AAC.00698-21.
2
Effectiveness of ceftazidime-avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia.头孢他啶-阿维巴坦与黏菌素治疗碳青霉烯类耐药肠杆菌科菌血症的疗效比较。
Int J Infect Dis. 2021 Aug;109:1-7. doi: 10.1016/j.ijid.2021.05.079. Epub 2021 Jun 4.
3
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials.
姆塔塔及周边医院耐碳青霉烯类肠杆菌科细菌(CRE)中替加环素耐药性的分子分析
Antibiotics (Basel). 2025 Apr 16;14(4):407. doi: 10.3390/antibiotics14040407.
4
Systematic review of multidrug-resistant in the Arabian Peninsula: molecular epidemiology and resistance patterns.阿拉伯半岛多重耐药性的系统评价:分子流行病学与耐药模式
Front Microbiol. 2025 Jan 24;16:1489317. doi: 10.3389/fmicb.2025.1489317. eCollection 2025.
5
High prevalence of antimicrobial resistance genes in multidrug-resistant-ESBLs-producing post-COVID-19 pandemic.新冠疫情后产超广谱β-内酰胺酶多重耐药菌中抗菌药物耐药基因的高流行率
Iran J Microbiol. 2024 Dec;16(6):745-754. doi: 10.18502/ijm.v16i6.17247.
6
Treatment of a challenging NDM and OXA-48-producing causing skin and soft tissue infection and exhibiting resistance to the combination of Ceftazidime-Avibactam and Aztreonam: A case report.治疗一例具有挑战性的产NDM和OXA-48且引起皮肤和软组织感染并对头孢他啶-阿维巴坦和氨曲南联合用药耐药的病例报告
IDCases. 2024 Jul 2;37:e02020. doi: 10.1016/j.idcr.2024.e02020. eCollection 2024.
7
Clinical and epidemiological characteristics of multi-drug resistant isolated from King Fahad Hospital of the University, AlKhobar, Saudi Arabia.沙特阿拉伯阿尔科巴尔法赫德国王大学医院分离的耐多药 株的临床和流行病学特征。
J Med Life. 2024 Jan;17(1):41-49. doi: 10.25122/jml-2023-0189.
8
Molecular Screening of Carbapenem-Resistant (CRKP) Clinical Isolates for Concomitant Occurrence of Genes (CTX-M, TEM, and SHV) in the Kingdom of Bahrain.巴林王国对耐碳青霉烯类肺炎克雷伯菌(CRKP)临床分离株进行基因(CTX-M、TEM和SHV)共现情况的分子筛查。
J Clin Med. 2023 Dec 5;12(24):7522. doi: 10.3390/jcm12247522.
9
Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia.肺炎克雷伯菌菌血症的流行病学:沙特阿拉伯利雅得法赫德国王医疗城分离株的耐药谱和临床结局。
BMC Infect Dis. 2023 Sep 5;23(1):579. doi: 10.1186/s12879-023-08563-8.
10
An Overview of Antimicrobial Resistance in Saudi Arabia (2013-2023) and the Need for National Surveillance.沙特阿拉伯的抗菌药物耐药性概述(2013 - 2023年)及国家监测的必要性
Microorganisms. 2023 Aug 15;11(8):2086. doi: 10.3390/microorganisms11082086.
黏菌素肾毒性:随机对照试验的荟萃分析
Open Forum Infect Dis. 2021 Jan 21;8(2):ofab026. doi: 10.1093/ofid/ofab026. eCollection 2021 Feb.
4
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.头孢他啶-阿维巴坦治疗碳青霉烯类耐药肠杆菌科细菌感染的疗效。
BMC Infect Dis. 2019 Sep 4;19(1):772. doi: 10.1186/s12879-019-4409-1.
5
Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.耐碳青霉烯肠杆菌科:来自沙特阿拉伯的更新叙述性综述。
J Infect Public Health. 2019 Jul-Aug;12(4):465-471. doi: 10.1016/j.jiph.2019.03.024. Epub 2019 May 3.
6
Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.碳青霉烯类耐药对中低收入国家肠杆菌科血流感染结局的影响(PANORAMA):一项多中心前瞻性队列研究。
Lancet Infect Dis. 2019 Jun;19(6):601-610. doi: 10.1016/S1473-3099(18)30792-8. Epub 2019 Apr 29.
7
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.定义新型针对碳青霉烯类耐药革兰氏阴性菌的β-内酰胺类药物的作用。
J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):251-260. doi: 10.1093/jpids/piz002.
8
Epidemiology of common resistant bacterial pathogens in the countries of the Arab League.阿拉伯国家常见耐药细菌病原体的流行病学。
Lancet Infect Dis. 2018 Dec;18(12):e379-e394. doi: 10.1016/S1473-3099(18)30414-6. Epub 2018 Oct 3.
9
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.亚胺培南-西司他丁钠和美罗培南-法硼巴坦:两种新型碳青霉烯-β-内酰胺酶抑制剂复方制剂。
Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9.
10
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.多黏菌素与头孢他啶-阿维巴坦治疗碳青霉烯类耐药肠杆菌科细菌感染。
Clin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.